RemeGen Co. Ltd. Class A

Direct answer

RemeGen Co. Ltd. Class A is publicly traded on SHH under the ticker 688331.SS.

RemeGen Co., Ltd., a biopharmaceutical company, discovers, develops, produces, and commercializes biological drugs for the treatment of autoimmune, oncology, and ophthalmic diseases in Mainland China and the United States. The company offers Telitacicept (RC18) for the treatment of systemic lupus erythematosus (SLE) autoimmune disease, rheumatoid arthritis, and myasthenia gravis; and Disitamab Vedotin (RC48), an...

Can you invest in RemeGen Co. Ltd. Class A?

Yes. RemeGen Co. Ltd. Class A is publicly traded on SHH under the ticker 688331.SS.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for RemeGen Co. Ltd. Class A

Detailed equity research is provided by MarketSnap.